申请人:Sterling Drug Inc.
公开号:US03956333A1
公开(公告)日:1976-05-11
(1-R- or 3-trifluoromethyl)-3,4-dihydro-2(1H)-isoquinolinecarboxamidoximes where R is pentafluoroethyl or heptafluoropropyl, having antithrombotic and antibacterial activities, are prepared by reacting the corresponding (1-R- or 3-trifluoromethyl)-3,4-dihydro-2(1H)-isoquinolinecarbonitriles which are prepared from the corresponding (1-R- or 3-trifluoromethyl)-3,4-dihydroisoquinolines via the (1-R- or 3-trifluoromethyl)-1,2,3,4-tetrahydroisoquinolines. Said tetrahydroisoquinoline where R is pentafluoroethyl also has antibacterial activity.
制备具有抗血栓和抗菌活性的(1-R-或3-三氟甲基)-3,4-二氢-2(1H)-异喹啉羧酰肟,其中R为五氟乙基或七氟丙基,通过反应相应的(1-R-或3-三氟甲基)-3,4-二氢-2(1H)-异喹啉碳腈制备,该碳腈是通过从相应的(1-R-或3-三氟甲基)-3,4-二氢异喹啉经过(1-R-或3-三氟甲基)-1,2,3,4-四氢异喹啉制备而来的。其中,R为五氟乙基的四氢异喹啉也具有抗菌活性。